查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
2016105

动脉动脉粥状硬化斑块切除术器械市场报告：按产品应用、最终用户和地区划分（2026-2034 年）

Atherectomy Devices Market Report by Product Application, End User, and Region 2026-2034
出版日期: | 出版商: IMARC | 英文 148 Pages | 商品交期: 2-3个工作天内

价格

2025年，全球动脉粥状硬化斑块切除术器械市场规模达10.664亿美元。展望未来，IMARC集团预测，到2034年，该市场规模将达到15.537亿美元，2026年至2034年的复合年增长率（CAGR）为4.14%。动脉粥状硬化切除器械市场成长的主要驱动因素包括週边动脉粥状硬化斑块切除术周边动脉疾病（PAD）盛行率的上升、技术的显着进步、人口老化、微创手术的普及、医疗基础设施的改善以及新兴国家的医保报销政策。

动脉粥状硬化斑块切除术器械市场趋势：

周边动脉疾病（PAD）病例增加

受人口老化以及糖尿病和肥胖症发病率上升的影响，全球动脉周围动脉斑块（PAD）的盛行率不断增加，推动了动脉粥状硬化斑块切除术器械市场的成长。在美国，约有800万至1200万人患有PAD，其中50岁以上的人特别突出。在这800万人中，有650万人被诊断出患有PAD且年龄超过40岁。动脉动脉粥状硬化斑块切除术器械提供了一种微创方法来清除动脉斑块，使其成为血管介入治疗的重要选择。这些器械可以改善血流，缓解腿痛和疲劳等症状。透过直接切除或汽化斑块，这些器械可以恢復动脉通畅性，显着改善重度PAD患者的预后。

技术进步

动脉粥状硬化斑块切除术装置的关键技术创新包括方向可控装置的出现和高频旋转技术的引入，这些创新不断提高装置的有效性和安全性。例如，2020 年的一项研究表明，轨道动脉粥状硬化斑块切除术（一种去除斑块的方法）可以有效开通闭塞的下肢动脉，成功率高达 90%，而雷射动脉粥状硬化斑块切除术也能达到类似的血流改善效果，成功率为 76%。患者预后的改善以及外科医生对这些装置的日益青睐，推动了动脉粥状硬化斑块切除术装置的发展。在一项纳入 172 名患者的多中心研究中，Jetstream 装置的使用证实了 99% 的装置成功率，临床评估的 6 个月和 12 个月重组率分别为 15% 和 26%。此外，基于双功能超音波成像的 1 年再血管再阻塞率为 38%。

进入新兴市场

主要市场参与者将目光投向医疗基础设施正在发展、医疗支出不断增长的新兴经济体，这为市场中的关键参与者创造了新的机会。例如，巴西、俄罗斯、印度、中国和南非（金砖国家）等新兴市场正日益影响全球医疗产品和服务的供需趋势。预计2030年，医疗支出占GDP的比例将分别达到巴西8.4%、俄罗斯5.2%、印度3.5%、中国5.9%和南非10.4%。更先进治疗方法的普及为进入这些市场提供了可能，从而推动了动脉粥状硬化斑块切除术设备在全球的推广应用。

目录

第一章：序言

第二章：调查方法

  • 调查目的
  • 相关利益者
  • 数据来源
    • 主要讯息
    • 次要讯息
  • 市场估值
    • 自下而上的方法
    • 自上而下的方法
  • 预测方法

第三章执行摘要

第四章：引言

第五章：全球动脉粥状硬化斑块切除术器械市场

  • 市场概览
  • 市场表现
  • 新冠疫情的影响
  • 市场预测

第六章 市场区隔：依产品划分

  • 定向斑块动脉粥状硬化斑块切除术装置
  • 轨道AAS选择切除装置
  • 光消融动脉粥状斑块动脉粥状硬化斑块切除术装置
  • 旋转式动脉粥状硬化斑块切除术装置
  • 支援的设备

第七章 市场区隔：依应用领域划分

  • 週边血管
  • 心血管系统
  • 神经血管

第八章 市场区隔：依最终用户划分

  • 医院
  • 门诊手术中心
  • 研究实验室和学术机构

第九章 市场区隔：依地区划分

  • 北美洲
    • 我们
    • 加拿大
  • 亚太地区
    • 中国
    • 日本
    • 印度
    • 韩国
    • 澳洲
    • 印尼
    • 其他的
  • 欧洲
    • 德国
    • 法国
    • 英国
    • 义大利
    • 西班牙
    • 俄罗斯
    • 其他的
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 其他的
  • 中东和非洲

第十章 SWOT 分析

第十一章：价值链分析

第十二章：波特五力分析

第十三章：价格分析

第十四章 竞争格局

  • 市场结构
  • 主要企业
  • 主要企业简介
    • Abbott Laboratories
    • Avinger
    • B. Braun Melsungen AG
    • Biomerics
    • Biotronik
    • Boston Scientific Corporation
    • CR Bard（Becton, Dickinson and Company）
    • Cardinal Health Inc.
    • Koninklijke Philips NV
    • Medtronic
    • Minnetronix Inc.
    • Straub Medical AG（Becton, Dickinson and Company）
    • Terumo Corporation
Product Code: SR112026A2766

The global atherectomy devices market size reached USD 1,066.4 Million in 2025. Looking forward, IMARC Group expects the market to reach USD 1,553.7 Million by 2034, exhibiting a growth rate (CAGR) of 4.14% during 2026-2034. The rise in peripheral artery disease (PAD), significant technological advancements, rising ageing population, advent of minimally invasive surgeries, development of healthcare infrastructure, and reimbursement policies in emerging economies represent some of the key factors driving the growth of the atherectomy market.

Atherectomy Devices Market Trends:

Rising Cases of Peripheral Artery Disease (PAD)

The increasing cases of PAD at a global level due to ageing population and the rise in diabetes and obesity is leading the atherectomy device market growth. Approximately, PAD affects 8 to 12 million people in the United States, especially in those over 50. Out of these, 6.5 million over the age of 40 are diagnosed with PAD. Atherectomy devices provide a minimally invasive approach to remove arterial plaque as it is an important alternative in vascular interventions. The device enhances blood flow and reduces symptoms such as leg pain and fatigue. By directly cutting away or vaporizing the plaque, these devices help restore arterial patency, significantly improving patient outcomes in individuals with severe forms of PAD.

Technological Advancements

Major atherectomy devices innovations include the appearance of directionally controlled devices and high-frequency rotational technologies, which have continued to improve the effectiveness and safety of these devices. For instance, a 2020 study suggests that orbital atherectomy (which sands down plaque) effectively opens up blocked leg arteries 90 percent of the time, while laser atherectomy achieves similarly improved blood flow 76 percent of the time. These improvements in patient outcome and surgeon preference for these devices are propelling the growth of the atherectomy devices. In a multicenter study of 172 patients, Jetstream use had a 99% device success, and six-month and 12-month clinically-driven, target-lesion revascularization rates of 15% and 26%, respectively; with a one-year restenosis rate of 38% based on duplex imaging.

Expansion into Emerging Markets

Prominent key players are focusing on emerging economies where healthcare infrastructure development and growing healthcare spending is focused, thereby creating new opportunities for the key players in the market. For instance, the emerging markets of Brazil, Russia, India, China, and South Africa (BRICS) are increasingly shaping the landscape of the global health sector demand and supply for medical goods and services. Health spending as a percentage of GDP in 2030 is projected as - Brazil, 8.4%; Russia, 5.2%; India, 3.5%; China, 5.9%; South Africa, 10.4%. The penetration into these markets is enabled by realization of more advanced treatment alternatives, thus expanding the global footprint of atherectomy devices.

Atherectomy Devices Market Segmentation:

The publisher provides an analysis of the key trends in each segment of the market, along with forecasts at the global, regional and country levels for 2026-2034. Our report has categorized the market based on product, application, and end user.

Breakup by Product:

  • Directional Atherectomy Devices
  • Orbital Atherectomy Devices
  • Photo-Ablative Atherectomy Devices
  • Rotational Atherectomy Devices
  • Support Devices

Directional Atherectomy Devices accounts for the majority of the market share

Directional atherectomy devices are created to precisely eliminate atherosclerotic plaque from obstructed arteries. These instruments provide the possibility of accurate control, which reduces vessel wall trauma, an important aspect for patient safety and recovery. Their ability to treat complex lesions in multiple vessel sizes makes them to be favoured by vascular specialists leading to the growth of the product segment. The capability of the devices to collect and remove plaque during the procedure sets these devices apart and is in a number of clinical situations preferable.

Breakup by Application:

  • Peripheral Vascular
  • Cardiovascular
  • Neurovascular

Peripheral Vascular accounts for the majority of the market share

The use of atherectomy devices in the treatment of peripheral vascular diseases is important because of the growing prevalence of PAD. Such devices play a key role in reestablishing the blood flow in leg arteries thus help to relieve the symptoms such as pain and mobility problems. The demand in this segment is determined by minimally invasive character of the procedure which allows short recovery period and lower risks of complications in comparison to conventional surgery making patient outcomes and treatment efficiencies higher.

Breakup by End User:

  • Hospitals
  • Ambulatory Surgery Centers
  • Research Laboratories and Academic Institutes

Hospitals accounts for the majority of the market share

Hospitals are the main users of atherectomy devices because these procedures are very complex and need advanced infrastructure and highly trained healthcare professionals. The growth of the segment is followed by the growth of the number of vascular surgeries conducted in hospitals, fueled by investments into advanced technologies and in the training programs of health providers. Ability of hospitals to offer all types of care including post-operative requirements also helps in making them the dominant subject in the market.

Breakup by Region:

  • North America
  • United States
  • Canada
  • Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Indonesia
  • Others
  • Europe
  • Germany
  • France
  • United Kingdom
  • Italy
  • Spain
  • Russia
  • Others
  • Latin America
  • Brazil
  • Mexico
  • Others
  • Middle East and Africa

North America dominates the market

The report has also provided a comprehensive analysis of all the major markets which include North America (United States, Canada); Asia-Pacific (China, Japan, India, South Korea, Australia, Indonesia, Others); Europe (Germany, France, United Kingdom, Italy, Spain, Russia, Others); Latin America (Brazil, Mexico, Others), and Middle East and Africa. According to the report, North America was the largest market for atherectomy devices.

North America is the largest market for atherectomy because of high prevalence of cardiovascular diseases, developed healthcare system and the key market players in the region. The United States is the biggest market in this region because of the favourable reimbursement scenarios, clinical trials, and solid governmental support for research and development in advanced medical devices. The commitment of the region to application of new healthcare solutions is driving the market growth.

Competitive Landscape:

  • The market research report has also provided a comprehensive analysis of the competitive landscape in the market. Detailed profiles of all major companies have been provided. Some of the major market players in the atherectomy devices market include Abbott Laboratories, Avinger, B. Braun Melsungen AG, Biomerics, Biotronik, Boston Scientific Corporation, C.R. Bard (Becton, Dickinson and Company), Cardinal Health, Koninklijke Philips N.V., Medtronic, Minnetronix Inc., Straub Medical AG (Becton, Dickinson and Company), and Terumo Corporation.
  • There is a dynamic market in atherectomy devices with the use of evolving strategies by major players in pursuit to grow their market share and to satisfy the increasing demand for minimally invasive surgery alternatives. One of these approaches is technical oriented, which is to say that the companies invest significantly in R&D to improve their devices that become therefore more efficient and safer. The second common event is strategic alliances and collaborations that support knowledge sharing and better distribution channels. In addition, mergers and acquisitions are common enabling companies to expand their product portfolios and geographical coverage. Approvals by regulatory bodies play an important role here as the companies are trying to meet tough norms that guarantee the efficiency and safety of their products in many markets.

Key Questions Answered in This Report

1. What was the size of the global atherectomy devices market in 2025?

2. What is the expected growth rate of the global atherectomy devices market during 2026-2034?

3. What has been the impact of COVID-19 on the global atherectomy devices market?

4. What are the key factors driving the global atherectomy devices market?

5. What is the breakup of the global atherectomy devices market based on the product?

6. What is the breakup of the global atherectomy devices market based on the application?

7. What is the breakup of the global atherectomy devices market based on the end user?

8. What are the key regions in the global atherectomy devices market?

9. Who are the key players/companies in the global atherectomy devices market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Atherectomy Devices Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Product

  • 6.1 Directional Atherectomy Devices
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Orbital Atherectomy Devices
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast
  • 6.3 Photo-Ablative Atherectomy Devices
    • 6.3.1 Market Trends
    • 6.3.2 Market Forecast
  • 6.4 Rotational Atherectomy Devices
    • 6.4.1 Market Trends
    • 6.4.2 Market Forecast
  • 6.5 Support Devices
    • 6.5.1 Market Trends
    • 6.5.2 Market Forecast

7 Market Breakup by Application

  • 7.1 Peripheral Vascular
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Cardiovascular
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 Neurovascular
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast

8 Market Breakup by End User

  • 8.1 Hospitals
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Ambulatory Surgery Centers
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Research Laboratories and Academic Institutes
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast

9 Market Breakup by Region

  • 9.1 North America
    • 9.1.1 United States
      • 9.1.1.1 Market Trends
      • 9.1.1.2 Market Forecast
    • 9.1.2 Canada
      • 9.1.2.1 Market Trends
      • 9.1.2.2 Market Forecast
  • 9.2 Asia Pacific
    • 9.2.1 China
      • 9.2.1.1 Market Trends
      • 9.2.1.2 Market Forecast
    • 9.2.2 Japan
      • 9.2.2.1 Market Trends
      • 9.2.2.2 Market Forecast
    • 9.2.3 India
      • 9.2.3.1 Market Trends
      • 9.2.3.2 Market Forecast
    • 9.2.4 South Korea
      • 9.2.4.1 Market Trends
      • 9.2.4.2 Market Forecast
    • 9.2.5 Australia
      • 9.2.5.1 Market Trends
      • 9.2.5.2 Market Forecast
    • 9.2.6 Indonesia
      • 9.2.6.1 Market Trends
      • 9.2.6.2 Market Forecast
    • 9.2.7 Others
      • 9.2.7.1 Market Trends
      • 9.2.7.2 Market Forecast
  • 9.3 Europe
    • 9.3.1 Germany
      • 9.3.1.1 Market Trends
      • 9.3.1.2 Market Forecast
    • 9.3.2 France
      • 9.3.2.1 Market Trends
      • 9.3.2.2 Market Forecast
    • 9.3.3 United Kingdom
      • 9.3.3.1 Market Trends
      • 9.3.3.2 Market Forecast
    • 9.3.4 Italy
      • 9.3.4.1 Market Trends
      • 9.3.4.2 Market Forecast
    • 9.3.5 Spain
      • 9.3.5.1 Market Trends
      • 9.3.5.2 Market Forecast
    • 9.3.6 Russia
      • 9.3.6.1 Market Trends
      • 9.3.6.2 Market Forecast
    • 9.3.7 Others
      • 9.3.7.1 Market Trends
      • 9.3.7.2 Market Forecast
  • 9.4 Latin America
    • 9.4.1 Brazil
      • 9.4.1.1 Market Trends
      • 9.4.1.2 Market Forecast
    • 9.4.2 Mexico
      • 9.4.2.1 Market Trends
      • 9.4.2.2 Market Forecast
    • 9.4.3 Others
      • 9.4.3.1 Market Trends
      • 9.4.3.2 Market Forecast
  • 9.5 Middle East and Africa
    • 9.5.1 Market Trends
    • 9.5.2 Market Breakup by Country
    • 9.5.3 Market Forecast

10 SWOT Analysis

  • 10.1 Overview
  • 10.2 Strengths
  • 10.3 Weaknesses
  • 10.4 Opportunities
  • 10.5 Threats

11 Value Chain Analysis

12 Porters Five Forces Analysis

  • 12.1 Overview
  • 12.2 Bargaining Power of Buyers
  • 12.3 Bargaining Power of Suppliers
  • 12.4 Degree of Competition
  • 12.5 Threat of New Entrants
  • 12.6 Threat of Substitutes

13 Price Analysis

14 Competitive Landscape

  • 14.1 Market Structure
  • 14.2 Key Players
  • 14.3 Profiles of Key Players
    • 14.3.1 Abbott Laboratories
      • 14.3.1.1 Company Overview
      • 14.3.1.2 Product Portfolio
      • 14.3.1.3 Financials
      • 14.3.1.4 SWOT Analysis
    • 14.3.2 Avinger
      • 14.3.2.1 Company Overview
      • 14.3.2.2 Product Portfolio
      • 14.3.2.3 Financials
    • 14.3.3 B. Braun Melsungen AG
      • 14.3.3.1 Company Overview
      • 14.3.3.2 Product Portfolio
      • 14.3.3.3 Financials
      • 14.3.3.4 SWOT Analysis
    • 14.3.4 Biomerics
      • 14.3.4.1 Company Overview
      • 14.3.4.2 Product Portfolio
    • 14.3.5 Biotronik
      • 14.3.5.1 Company Overview
      • 14.3.5.2 Product Portfolio
      • 14.3.5.3 Financials
      • 14.3.5.4 SWOT Analysis
    • 14.3.6 Boston Scientific Corporation
      • 14.3.6.1 Company Overview
      • 14.3.6.2 Product Portfolio
      • 14.3.6.3 Financials
      • 14.3.6.4 SWOT Analysis
    • 14.3.7 C.R. Bard (Becton, Dickinson and Company)
      • 14.3.7.1 Company Overview
      • 14.3.7.2 Product Portfolio
    • 14.3.8 Cardinal Health Inc.
      • 14.3.8.1 Company Overview
      • 14.3.8.2 Product Portfolio
      • 14.3.8.3 Financials
      • 14.3.8.4 SWOT Analysis
    • 14.3.9 Koninklijke Philips N.V.
      • 14.3.9.1 Company Overview
      • 14.3.9.2 Product Portfolio
      • 14.3.9.3 Financials
      • 14.3.9.4 SWOT Analysis
    • 14.3.10 Medtronic
      • 14.3.10.1 Company Overview
      • 14.3.10.2 Product Portfolio
    • 14.3.11 Minnetronix Inc.
      • 14.3.11.1 Company Overview
      • 14.3.11.2 Product Portfolio
    • 14.3.12 Straub Medical AG (Becton, Dickinson and Company)
      • 14.3.12.1 Company Overview
      • 14.3.12.2 Product Portfolio
    • 14.3.13 Terumo Corporation
      • 14.3.13.1 Company Overview
      • 14.3.13.2 Product Portfolio
      • 14.3.13.3 Financials
      • 14.3.13.4 SWOT Analysis

List of Figures

  • Figure 1: Global: Atherectomy Devices Market: Sales Value (in Million USD), 2020-2025
  • Figure 2: Global: Atherectomy Devices Market: Breakup by Product (in %), 2025
  • Figure 3: Global: Atherectomy Devices Market: Breakup by Application (in %), 2025
  • Figure 4: Global: Atherectomy Devices Market: Breakup by End User (in %), 2025
  • Figure 5: Global: Atherectomy Devices Market: Breakup by Region (in %), 2025
  • Figure 6: Global: Atherectomy Devices Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 7: Global: Atherectomy Devices (Directional Atherectomy Devices) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 8: Global: Atherectomy Devices (Directional Atherectomy Devices) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 9: Global: Atherectomy Devices (Orbital Atherectomy Devices) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 10: Global: Atherectomy Devices (Orbital Atherectomy Devices) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 11: Global: Atherectomy Devices (Photo-Ablative Atherectomy Devices) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 12: Global: Atherectomy Devices (Photo-Ablative Atherectomy Devices) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 13: Global: Atherectomy Devices (Rotational Atherectomy Devices) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 14: Global: Atherectomy Devices (Rotational Atherectomy Devices) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 15: Global: Atherectomy Devices (Support Devices) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 16: Global: Atherectomy Devices (Support Devices) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 17: Global: Atherectomy Devices (Peripheral Vascular) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 18: Global: Atherectomy Devices (Peripheral Vascular) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 19: Global: Atherectomy Devices (Cardiovascular) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 20: Global: Atherectomy Devices (Cardiovascular) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 21: Global: Atherectomy Devices (Neurovascular) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 22: Global: Atherectomy Devices (Neurovascular) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 23: Global: Atherectomy Devices (Hospitals) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 24: Global: Atherectomy Devices (Hospitals) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 25: Global: Atherectomy Devices (Ambulatory Surgery Centers) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 26: Global: Atherectomy Devices (Ambulatory Surgery Centers) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 27: Global: Atherectomy Devices (Research Laboratories and Academic Institutes) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 28: Global: Atherectomy Devices (Research Laboratories and Academic Institutes) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 29: North America: Atherectomy Devices Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 30: North America: Atherectomy Devices Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 31: United States: Atherectomy Devices Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 32: United States: Atherectomy Devices Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 33: Canada: Atherectomy Devices Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 34: Canada: Atherectomy Devices Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 35: Asia Pacific: Atherectomy Devices Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 36: Asia Pacific: Atherectomy Devices Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 37: China: Atherectomy Devices Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 38: China: Atherectomy Devices Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 39: Japan: Atherectomy Devices Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 40: Japan: Atherectomy Devices Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 41: India: Atherectomy Devices Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 42: India: Atherectomy Devices Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 43: South Korea: Atherectomy Devices Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 44: South Korea: Atherectomy Devices Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 45: Australia: Atherectomy Devices Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 46: Australia: Atherectomy Devices Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 47: Indonesia: Atherectomy Devices Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 48: Indonesia: Atherectomy Devices Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 49: Others: Atherectomy Devices Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 50: Others: Atherectomy Devices Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 51: Europe: Atherectomy Devices Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 52: Europe: Atherectomy Devices Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 53: Germany: Atherectomy Devices Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 54: Germany: Atherectomy Devices Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 55: France: Atherectomy Devices Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 56: France: Atherectomy Devices Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 57: United Kingdom: Atherectomy Devices Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 58: United Kingdom: Atherectomy Devices Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 59: Italy: Atherectomy Devices Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 60: Italy: Atherectomy Devices Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 61: Spain: Atherectomy Devices Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 62: Spain: Atherectomy Devices Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 63: Russia: Atherectomy Devices Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 64: Russia: Atherectomy Devices Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 65: Others: Atherectomy Devices Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 66: Others: Atherectomy Devices Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 67: Latin America: Atherectomy Devices Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 68: Latin America: Atherectomy Devices Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 69: Brazil: Atherectomy Devices Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 70: Brazil: Atherectomy Devices Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 71: Mexico: Atherectomy Devices Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 72: Mexico: Atherectomy Devices Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 73: Others: Atherectomy Devices Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 74: Others: Atherectomy Devices Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 75: Middle East and Africa: Atherectomy Devices Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 76: Middle East and Africa: Atherectomy Devices Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 77: Global: Atherectomy Devices Industry: SWOT Analysis
  • Figure 78: Global: Atherectomy Devices Industry: Value Chain Analysis
  • Figure 79: Global: Atherectomy Devices Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Atherectomy Devices Market: Key Industry Highlights, 2025 and 2034
  • Table 2: Global: Atherectomy Devices Market Forecast: Breakup by Product (in Million USD), 2026-2034
  • Table 3: Global: Atherectomy Devices Market Forecast: Breakup by Application (in Million USD), 2026-2034
  • Table 4: Global: Atherectomy Devices Market Forecast: Breakup by End User (in Million USD), 2026-2034
  • Table 5: Global: Atherectomy Devices Market Forecast: Breakup by Region (in Million USD), 2026-2034
  • Table 6: Global: Atherectomy Devices Market: Competitive Structure
  • Table 7: Global: Atherectomy Devices Market: Key Players